Biomeksin

Active substance:

• ethylmethylhydroxypyridine succinate – 50 mg;

Excipient:

• water for injection – up to 1 ml.

• Acute cerebrovascular accidents;
• encephalopathy;
• vegetative-vascular dystonia;
• mild cognitive disorders of atherosclerotic origin;
• anxiety, neurotic and neurosis-like conditions; acute and chronic ischemic heart disease (as part of combination therapy);
• angiopathy of the lower extremities in type II diabetes mellitus (as part of combination therapy);
• period after chemotherapy (as part of combination therapy);
• relief of withdrawal syndrome in alcoholism with a predominance of neurosis-like and vegetative-vascular disorders;
• acute intoxication with antipsychotic drugs;
• acute purulent-inflammatory processes of the abdominal cavity (acute pancreatitis, peritonitis) with complex therapy.

It is prescribed to young patients for traumatic brain injuries and purulent neuroinfections. In this case, systematic medical monitoring and correction strictly according to medical indications are clearly required.

The injection solution is administered intramuscularly or intravenously (stream or drip).

To prepare a solution for infusion, the drug should be diluted with isotonic sodium chloride solution.

Doses are selected individually depending on the pathology and severity of the condition by increasing the patient’s dose.

• The initial dose is 50-100 mg 3 times a day with gradual dosage until a therapeutic effect is obtained.
• The maximum daily dose is 800 mg.
• Biomexin is injected slowly over 5-7 minutes, dropwise at a rate of 40-60 drops/min.